gemfibrozil has been researched along with thromboxane b2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koskinen, P; Lassila, R; Laustiola, K; Manninen, V; Pellinen, T | 1 |
1 trial(s) available for gemfibrozil and thromboxane b2
| Article | Year |
|---|---|
Gemfibrozil decreases platelet reactivity in patients with hypercholesterolemia during physical stress.
Topics: Adult; Blood Platelets; Clinical Trials as Topic; Gemfibrozil; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Physical Exertion; Platelet Aggregation; Thromboxane B2; Valerates | 1988 |